KCA Neurology, PLLC

The trials here

What the 5 trials at this site are about, from their registry records.

Conditions

• Migraine4 trials
• Alzheimer disease1 trial

Phase

• Phase 33 trials
• Phase 2/31 trial
• Phase 41 trial

Status

• Active, not recruiting2 trials
• Terminated2 trials
• Completed1 trial

Lead sponsor

• Ipsen2 trials
• Cassava Sciences, Inc.1 trial
• H. Lundbeck A/S1 trial
• Pfizer1 trial

Running trials

• Active, not recruiting

  A Study to Evaluate the Effectiveness and Safety of Dysport® for the Prevention of Chronic Migraine in Adults

  NCT06047444· Phase 3· Ipsen· Source

• Active, not recruiting

  A Study to Evaluate the Effectiveness and Safety of Dysport® for the Prevention of Episodic Migraine in Adults

  NCT06047457· Phase 3· Ipsen· Source

Closed trials

• Completed

  A Trial of Eptinezumab in Participants With Migraine and Insufficient Response to Anti-CGRP Medications

  NCT06701526· Phase 4· H. Lundbeck A/S· Source

• Terminated

  Simufilam 50 mg or 100 mg for Mild-to-Moderate Alzheimer's Disease

  NCT05026177· Phase 3· Cassava Sciences, Inc.· Source

• Terminated

  A Study to Evaluate the Efficacy and Safety of Oral Zavegepant in Migraine Prevention

  NCT04804033· Phase 2/3· Pfizer· Source